Literature DB >> 8422426

The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts.

A V Ferrao1, R M Mason.   

Abstract

(1), A commercial heparin inhibited the proliferation of two normal human dermal fibroblast cultures in a dose-responsive manner. 300 micrograms heparin/ml gave the maximum inhibition of 65%. Proliferation of fibroblasts from a patient with progressive systemic sclerosis was similarly inhibited by heparin. Heparan sulphate, pentosan polysulphate and a fucoidan also inhibited proliferation of the fibroblast cultures but chondroitin sulphate, dermatan sulphate and hyaluronate had no effect. (2) Type-I collagen synthesis per cell was elevated by up to 1.5-fold in the normal fibroblast cultures when proliferation was inhibited by heparin, heparan sulphate, pentosan polysulphate and the fucoidan. Progressive systemic sclerosis fibroblasts synthesized more collagen than the normal cell cultures and this was further stimulated by heparin and pentosan polysulphate. In contrast, heparin and the other polysulphates inhibited type-I collagen synthesis by about 20-30% in normal confluent fibroblast cultures. Collagen synthesis by confluent systemic sclerosis fibroblasts was reduced by only about 10%. (3), Total [35S]proteoglycan synthesis per cell was greatly elevated (approx. 2.5-fold) in normal subconfluent cultures treated with heparin. In contrast, heparin stimulated only a small increase in [35S]sulphate incorporation into proteoglycans in confluent cultures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422426     DOI: 10.1016/0925-4439(93)90042-y

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  A comparative study of paediatric thermal burns treated with topical heparin and without heparin.

Authors:  T S Venkatachalapathy
Journal:  Indian J Surg       Date:  2012-10-05       Impact factor: 0.656

2.  Different mechanisms regulate phosphatidylserine synthesis in rat cerebral cortex.

Authors:  R Mozzi; V Andreoli; S Buratta; A Iorio
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

3.  A heparin-mimicking reverse thermal gel for controlled delivery of positively charged proteins.

Authors:  Brisa Peña; Robin Shandas; Daewon Park
Journal:  J Biomed Mater Res A       Date:  2014-10-21       Impact factor: 4.396

4.  Mast cells: the forgotten cells of renal fibrosis.

Authors:  I S Roberts; P E Brenchley
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

5.  Heparin reduced mortality and sepsis in severely burned children.

Authors:  G J Zayas; A M Bonilla; M J Saliba
Journal:  Ann Burns Fire Disasters       Date:  2007-03-31

6.  Effect of heparin on dextran sulfate sodium-induced colitis.

Authors:  J R Korzenik; A Hsu; M E Robert
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 7.  Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD.

Authors:  Zhenyu Qin; Krzysztof J Reszka; Tohru Fukai; Neal L Weintraub
Journal:  Transl Res       Date:  2007-11-08       Impact factor: 7.012

8.  Does low molecular weight heparin impair anastomotic wound healing?

Authors:  Emre Ergul; Yigit Mehmet Ozgun; Gulten Kiyak; Gonca Barit Ozgun; Birol Korukluoglu; Ahmet Kusdemir
Journal:  J Gastrointest Surg       Date:  2008-12-13       Impact factor: 3.452

9.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

10.  Binding and growth-inhibitory effect of heparin and oligo-heparin (2kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover.

Authors:  S Cavari; G Fiorelli; S Vannucchi
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.